Across TCGA pan-cancer cohorts, LINC01763 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC01763’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01763 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01763 is over-expressed in tumor, although a few such as THCA and COAD show the opposite, repressed pattern.

KIRC, HNSC, and LUAD are the cancer types where LINC01763 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01763 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	+0.030	.022	4	view →
HNSC	All	III,IV	+0.025	.033	3	view →
LUAD	All	All	+0.044	.046	1	view →
THCA	All	All	−0.032	.031	1	view →
COAD	All	II,III,IV	−0.021	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: LINC01763 RNA expression & survival · all LINC01763 data types